...
首页> 外文期刊>Urology >Detection of a non-Hodgkin's lymphoma by capromab pendetide scintigraphy (ProstaScint) in a patient with prostate carcinoma.
【24h】

Detection of a non-Hodgkin's lymphoma by capromab pendetide scintigraphy (ProstaScint) in a patient with prostate carcinoma.

机译:Capromab pendetide闪烁显像术(ProstaScint)在患有前列腺癌的患者中检测到非霍奇金淋巴瘤。

获取原文
获取原文并翻译 | 示例
           

摘要

A 77-year-old man with Gleason score 7 prostate cancer, after radical prostatectomy, in whom the prostate-specific antigen level increased to 5.0 ng/mL 8 years later, underwent a ProstaScint scan. Radiotracer deposition was noted in the prostatic "fossa," highly suspicious of recurrence. An additional focus in the mid abdomen was suspicious of adenopathy. Computed tomography disclosed an abdominal mass that, at biopsy, proved to be a malignant B-cell lymphoma. That lesion resolved after chemotherapy, and the prostate-specific antigen level substantially decreased with hormonal treatment. The possible association of prostate cancer and lymphoma is discussed.
机译:一名进行前列腺癌根治术的Gleason评分为7岁的前列腺癌患者在前列腺癌根治术后7年进行了ProstaScint扫描,其中前列腺特异性抗原水平在8年后增加至5.0 ng / mL。放射性“示踪剂”沉积在前列腺“窝”中被发现,高度怀疑其复发。腹部中部的另一个焦点是可疑的腺病。计算机断层扫描显示腹部肿块,经活检证实为恶性B细胞淋巴瘤。该病变在化学疗法后消退,并且通过激素治疗前列腺特异性抗原水平显着降低。讨论了前列腺癌和淋巴瘤的可能联系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号